Latest Features & Opinion
The Clinton Foundation's Health Matters Initiative, in partnership with the Johns Hopkins Bloomberg School of Public Health, issued a report providing 49 recommendations under 10 topic areas on how to address the opioid crisis.
Despite its prevalence, tension-type headache is often complicated by overlapping symptoms and a weak understanding of tension-type headache etiology.
Systemic lidocaine administered via IV or patch has consistently shown effectiveness for the treatment and prevention of chronic pain.
Many translational barriers exist between preclinical research and clinical practice.
The most promising tools to predict acute pain after cesarean delivery are local anesthetic infiltration before placement of spinal anesthesia, and asking patients simple questions about anticipated pain and analgesic needs.
Depending on the extent of the injury, pain due to burns can range from mild to severe to excruciating.
Clinical Pain Advisor Articles
- Non-Opioid Therapies for Pain Management in the ED
- Betel Quid Addiction and Implications for Substance Use Disorder
- Low Back Pain: Contributing Factors, Prophylactic Strategies, and Effective Treatments
- Peripherally Acting Opioid and Cannabinoid May Be Effective for Neuropathic Pain
- New Blood Test Shows High Accuracy for Diagnosing Fibromyalgia
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- Opioids vs Nonopioid Medications for Chronic Back, Knee, and Hip Osteoarthritis Pain
- Conventional vs High-Frequency Spinal Cord Stimulation for Chronic Pain
- Evaluating Headache in the Elderly: Primary vs Secondary Causes
- Custom Foot Orthotics vs OTC Insoles for Plantar Heel Pain
- Once-Monthly Erenumab Injections May Be Effective for Episodic Migraine Prophylaxis